![]() |
市场调查报告书
商品编码
1279647
2022-2029年全球精准医疗市场规模研究和预测,按技术和应用及区域分析Global Precision Medicine Market Size study & Forecast, by Technology by Application, and Regional Analysis, 2022-2029 |
精准医学是一门新兴的科学,它将治疗决定集中在病人的基因特征、生活方式和环境上。精准医学在治疗癌症方面的成功导致了它的普及。它使医学专家和研究人员能够预测每一种具体疾病的更精确的治疗和预防措施。精准医学专注于将健康的身体细胞变成癌细胞的突变,通常被称为个性化医学或定制医学。与传统药物相比,精准医学在癌症靶向治疗中的应用提供了更少的不良反应,促进了更快的康复。由于中枢神经系统疾病发病率的增加和癌症生物学的进步等因素,精准医学市场正在扩大。
由于包括癌症和不常见疾病在内的严重疾病发病率的上升,这一领域已经产生了一些基因疗法、诊断法和药物。根据国际癌症研究机构(IARC)的估计,在全球范围内,2018年有1700万个新的癌症病例和950万个癌症相关的死亡病例。据估计,到2040年,全世界的癌症负担将增加到2750万新病例。此外,细胞生物学和技术的发展正在推动审查中的行业的发展。例如,2021年5月,AdventHealth推出了一个数据驱动的精准医疗倡议,作为其基因组学计划扩展的一部分。这项倡议组织和整合纵向病人数据与分子测试数据,从而建立一个数据集和疾病网络模型,帮助医疗系统更好地预测疾病的发生以及它们对治疗的反应。因此,这些发展正在推动增长。此外,精准医疗的技术进步和与精准医疗相关的投资增长正在为市场创造一个有利可图的增长。然而,精准医疗发展的高成本阻碍了市场增长。
全球精准医疗市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于品牌技术的主导地位和该地区日益增长的疾病流行率,北美在收入方面主导了市场。而亚太地区在预测期内预计将以最高的复合年增长率增长,原因是老年病的增加、药品开发合作数量的增加、主要参与者的地理扩张以及政府和非营利组织在市场空间的积极参与等因素。
该研究的目的是确定近年来不同领域和国家的市场规模,并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。
该报告还提供了关于关键方面的详细信息,如驱动因素和挑战,这将确定市场的未来增长。此外,它还纳入了微观市场的潜在机会,供利益相关者投资,以及对竞争格局和主要参与者的技术产品的详细分析。.
Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision medicine is an emerging science that focuses treatment decisions on a patient's genetic profile, way of life, and environment. The success of precision medicine in treating cancer has led to an increase in its popularity. It enables medical professionals and researchers to forecast more precise treatment and prevention measures for every specific disease. Precision medicine, which focuses on the mutations that turn healthy bodily cells into cancerous ones, is often referred to as personalized medicine or tailored medicine. In comparison to conventional medications, the use of precision medicine in targeted cancer treatment offers fewer adverse effects and promotes faster recovery. The Precision Medicine market is expanding because of factors such as increasing incidence of central nerves system disorders and advancement in cancer biology.
Several gene therapies, diagnostics, and medications have been created in this field as a result of the rise in the prevalence of serious illnesses including cancer and uncommon diseases. According to estimates from the International Agency for Research on Cancer (IARC), globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018. It is estimated to increase the worldwide burden of cancer to 27.5 million new cases by 2040. Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth launched a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative organize and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the growth. In addition, higher technological advancements of precision medicine and growing investments associated with precision medicine is creating a lucrative growth to the market. However, high cost for precision medicine development halt market growth.
The key regions considered for the Global Precision Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologies and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable